
|Articles|February 1, 2003
Treating refractive errors: U.S., international trials corroborate benefits of custom LASIK
Orlando-Results from international and U.S. FDA clinical trials point to the efficacy and safety of treating spherical and cylindrical refractive errors using the Zyoptix system for personalized vision correction (Bausch & Lomb), according to speakers at the refractive surgery subspecialty day held prior to the American Academy of Ophthalmology annual meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Optigo: Lead anti-VEGF program advancing toward IND-enabling studies
2
AAO 2025: Advancements in laser refractive surgery
3
From then to next: Five decades of transformation in ophthalmology
4
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
5


















































.png)


